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Abstract 
 
Comparing genes expressed in normal and 
diseased states assists the understanding of cancer 
pathophysiology, detection, prognosis, and therapeutic 
target study. Many existing expression analysis papers 
show that microarray data are usually case dependent, 
have small sample (patients) sizes, and have large 
gene dimensions.  Thus, we have been developing a 
robust multi-parameter, multi-scheme knowledge-
based optimization system that integrates the strengths 
of statistics, pattern-recognition, and support vector 
machines (SVM). The optimization logic identifies 
optimal cancer signature genes by utilizing different 
analysis models based on unsupervised and supervised 
clustering.  Our system is being finalized by testing 
over public and in-house datasets with the intention of 
validation through clinical knowledge feedback.   
 
1.  Introduction 
 
Microarray technology has dramatically increased 
the amount of data available to biologists in the last 
few years.  The advancement of this technology also 
presents a big challenge. In cancer research, the issue 
is how to identify the signature genes, or biomarkers 
associated with particular cancer to perform precise, 
objective and systematic cancer diagnosis and 
treatment. More specifically, the goal is how to 
accurately analyze and interpret the resulting large 
amount of gene expression data with relatively small 
patient sample size.  As such,  we have been 
developing a novel multi-scheme system that can 
derive optimal decision based on the best utilization of 
gene expression data features and clinical, and 
biological knowledge.  This process consists of 
grouping functionally similar genes or biomarkers into 
categories, revealing genetic relationships, and 
validating the grouping by cross-validation methods. 
In the early phase development of our novel 
system, we have used unsupervised clustering methods 
to discover gene relationship and used knowledge-
based supervised classification to get highly accurate 
prediction in cancer diagnosis and prognosis study.  
Specifically, hierarchical clustering and SVMs are 
combined to improve sample classification and feature 
selection.  The test data used in this  paper is a 
previously published breast cancer data  [1] and 
ovarian cancer data.  This work sets up foundation for 
our next step drug target study. 
 
2.  Background 
 
Unsupervised techniques analyze data without 
prior knowledge of how the data should be classified.  
Methods of unsupervised clustering include 
hierarchical clustering and self-organizing maps 
(SOM).    Unsupervised methods can analyze 
microarray data in two ways  –  (1) clustering 
microarray samples, comprising up to thousands of 
genes, to elucidate relationships between genetic 
expressions of different groups and (2) clustering 
genes to reveal expression profiles.  Similarities 
between samples can be defined using a variety of 
distance metrics [2].  Consequently, the choice of an 
appropriate distance metric is critical in order to reveal 
true underlying expression patterns beneath the 
samples.  By combining the analysis of these 
clustering patterns with prior knowledge of the 
samples, we achieve two objectives  –  (1) to extract 
marker genes that are significant in distinguishing the 
various classes of samples and (2) to identify the most 
efficient distance metric in revealing underlying 
cluster patterns.   
In contrast, supervised classification methods are 
based on learning machines that rely on data for which 
specific  classifications are already known.  These 
algorithms “learn” to classify data points provided by 
a limited training set comprised of a fraction of all 
available data.  Once the algorithm has learned from 
the training set, it can then accurately classify a related 
data set.  Methods for supervised learning include 
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SVMs have been shown to outperform neural 
networks[3], thus SVMs will be the main focus for 
supervised clustering methods in this paper.   
SVM optimization results in a hyperplane that can 
separate classes of data.  SVMs have an advantage 
over neural networks in that, for the case where data is 
not linearly separable, kernel functions can be used to 
map the data to a higher dimensional feature space [4].   
 
2.1.  Algorithms 
 
The rank comparison algorithm computes sets of 
weights for the SVM using a leave-one-out dataset for 
each element (sample) of the dataset.  Each weight set 
is then sorted, resulting in an ordered vector for each 
sample.  The weight values correspond to particular 
genes; furthermore, the magnitude of the weight value 
determines the significance of the corresponding gene.  
Significant genes should remain reasonably within the 
ends of the weight vector.   
The individual gene analysis algorithm performs 
slightly better than the rank comparison algorithm.  
For each gene, a complete leave-one-out validation is 
conducted on the samples.  This algorithm, however, 
is computationally intense because the number of 
optimizations is equal to the number of samples 
multiplied by the number of genes.  In order to 
complete calculations in a reasonable amount of time, 
data can be divided into blocks and analyzed 
separately.  Significant genes selected using this 
algorithm should result in higher prediction rates when 
validated.   
 
3.  Results 
 
Analysis of the breast cancer data using 
unsupervised hierarchical clustering produced erratic 
results.  However, analysis of the four class ovarian 
cancer data using features discovered by the individual 
feature analysis algorithm resulted in proper 
clustering.  
As expected, the rank comparison algorithm for 
the breast cancer data resulted in higher occurrence of 
significant genes at the beginning and end o f the 
sorted weight vector.  Using all 24,481 features of the 
breast cancer data in the complete leave-one-out 
algorithm on 78 samples resulted in a prediction rate 
of 88.46%.  Using significant genes from the rank 
comparison algorithm unexpectedly decreased the 
prediction rate and may be due to inherent problems 
with the rank comparison algorithm.   
Using the individual feature analysis algorithm 
resulted in slightly better performance.  The top 10 
genes obtained from this algorithm resulted in a 
prediction rate of 88.46%, but the top single gene 
dropped the prediction rate to 84.62%.   
The individual feature analysis algorithm was 
applied to each of the six pairs of classes for the 
ovarian cancer data resulting in six different sets of 
gene ranks.  In contrast to the breast cancer data a 
significant number of the ovarian cancer genes were 
able to accurately separate 100% of the samples.   
 
4.  Discussion 
 
Genes ranked using the individual feature analysis 
resulted in low prediction rates of around 80% using 
the breast cancer data.  The individual feature analysis 
algorithm may not be an accurate prediction of gene 
rank because each SVM optimization is 1-dimensional 
and is unlikely to be linearly separable.  It may be 
possible to use a fuzzy method or kernel functions to 
overcome the non-linear problem.   
Although the dimensionality of the feature 
selection algorithm fails for the breast cancer data, 
analysis of the ovarian cancer data produced decent 
results.  For several pairs of the four class data, a small 
number of genes were identified that could separate 
the classes with 100% accuracy.  The results from 
clustering the four-class ovarian cancer data shows 
that the combination of supervised and unsupervised 
clustering can provide a powerful tool for 
classification.  Features discovered using SVM 
methods could significantly improve unsupervised 
clustering methods.  Unsupervised clustering of the 
gene expression of microarray data may also help to 
identify related features to improve SVM algorithms.  
Future w ork will include further analysis of 
unsupervised clustering of the breast cancer data using 
SVM-identified features and modification of the SVM 
algorithms to address non-linear issues.   
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